PNC Financial Services Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-400
| Closed | -$39K | – | 4198 |
|
|
2019
Q3 | $39K | Hold |
400
| – | – | ﹤0.01% | 3050 |
|
|
2019
Q2 | $41K | Hold |
400
| – | – | ﹤0.01% | 3041 |
|
|
2019
Q1 | $46K | Sell |
400
-350
| -47% | -$25.7K | ﹤0.01% | 2992 |
|
|
2018
Q4 | $29K | Sell |
750
-2,175
| -74% | -$94.3K | ﹤0.01% | 3152 |
|
|
2018
Q3 | $160K | Buy |
2,925
+325
| +13% | +$22.2K | ﹤0.01% | 2310 |
|
|
2018
Q2 | $215K | Buy |
2,600
+500
| +24% | +$38.6K | ﹤0.01% | 2141 |
|
|
2018
Q1 | $140K | Buy |
2,100
+1,000
| +91% | +$57.7K | ﹤0.01% | 2373 |
|
|
2017
Q4 | $57K | Buy |
1,100
+400
| +57% | +$28.7K | ﹤0.01% | 2885 |
|
|
2017
Q3 | $62K | Hold |
700
| – | – | ﹤0.01% | 2812 |
|
|
2017
Q2 | $42K | Hold |
700
| – | – | ﹤0.01% | 3000 |
|
|
2017
Q1 | $37K | Hold |
700
| – | – | ﹤0.01% | 3030 |
|
|
2016
Q4 | $35K | Sell |
700
-150
| -18% | -$8.04K | ﹤0.01% | 3000 |
|
|
2016
Q3 | $52K | Buy |
850
+96
| +13% | +$5.53K | ﹤0.01% | 2803 |
|
|
2016
Q2 | $39K | Buy |
754
+4
| +0.5% | +$171 | ﹤0.01% | 2947 |
|
|
2016
Q1 | $22K | Hold |
750
| – | – | ﹤0.01% | 3249 |
|
|
2015
Q4 | $34K | Sell |
750
-50
| -6% | -$2.62K | ﹤0.01% | 3029 |
|
|
2015
Q3 | $33K | Buy |
800
+50
| +7% | +$2.61K | ﹤0.01% | 3122 |
|
|
2015
Q2 | $45K | Buy |
750
+50
| +7% | +$3.31K | ﹤0.01% | 3080 |
|
|
2015
Q1 | $54K | Buy |
+700
| New | +$40.3K | ﹤0.01% | 3012 |
|
PNC Financial Services Group's ONCE Position: Q4 2019 in Review
PNC Financial Services Group sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 400 shares — an estimated $39K sold.
PNC Financial Services Group first reported a position in ONCE in Q1 2015 and held it in 19 quarters. The position peaked at $215K in Q2 2018. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- PNC Financial Services Group reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- PNC Financial Services Group sold 400 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $39K.
- PNC Financial Services Group first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 19 quarters.
- PNC Financial Services Group's Spark Therapeutics, Inc. Common Stock position peaked at $215K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on PNC Financial Services Group's 13F filing for Q4 2019, filed 7 Feb 2020.